When large incumbents leave significant but challenging markets, leaner startups can leverage new technologies to drive change. As big pharmaceutical companies shy away from neurological disease research, Verge Genomics founder and CEO Alice Zhang describes how a confluence of technological advances in genomics is creating new opportunities. New nontraditional biotech companies, she observes, are being built by multidisciplinary teams fluent in both biology and computer science.
Related
![Photo of Alexandra Zatarain](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/05/Alexandra-Zatarain-600x600-1.png)
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
Video
50 minutes
Alexandra Zatarain,
Eight Sleep
Getting to Product-Market Fit [Entire Talk]
Product-market fit is a journey. Knowing your audience and mission will help you on your way.
![Photo of Maria Barrera](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/04/Maria-Barrera-600x600-.png)
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Video
49 minutes
Maria Barrera,
Clayful
Mental Health Tech, Mentally Healthy Startups [Entire Talk]
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
![Photo of David Allemann](https://ecorner.stanford.edu/wp-content/uploads/sites/2/2024/03/David-Allemann-600x600-2.png)
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.
Video
50 minutes
David Allemann,
On
Exploration in Sports Technology [Entire Talk]
Taking a risk on an innovative idea can be the spark of a global company.